These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11890994)

  • 1. Defining regions of loss of heterozygosity of 16q in breast cancer cell lines.
    Callen DF; Crawford J; Derwas C; Cleton-Jansen AM; Cornelisse CJ; Baker E
    Cancer Genet Cytogenet; 2002 Feb; 133(1):76-82. PubMed ID: 11890994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
    Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
    Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.
    Cleton-Jansen AM; Buerger H; Haar Nt; Philippo K; van de Vijver MJ; Boecker W; Smit VT; Cornelisse CJ
    Genes Chromosomes Cancer; 2004 Oct; 41(2):109-16. PubMed ID: 15287023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases.
    Driouch K; Dorion-Bonnet F; Briffod M; Champéme MH; Longy M; Lidereau R
    Genes Chromosomes Cancer; 1997 Jul; 19(3):185-91. PubMed ID: 9219000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
    Kochetkova M; McKenzie OL; Bais AJ; Martin JM; Secker GA; Seshadri R; Powell JA; Hinze SJ; Gardner AE; Spendlove HE; O'Callaghan NJ; Cleton-Jansen AM; Cornelisse C; Whitmore SA; Crawford J; Kremmidiotis G; Sutherland GR; Callen DF
    Cancer Res; 2002 Aug; 62(16):4599-604. PubMed ID: 12183414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers.
    Dorion-Bonnet F; Mautalen S; Hostein I; Longy M
    Genes Chromosomes Cancer; 1995 Nov; 14(3):171-81. PubMed ID: 8589033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.
    Cleton-Jansen AM; van Eijk R; Lombaerts M; Schmidt MK; Van't Veer LJ; Philippo K; Zimmerman RM; Peterse JL; Smit VT; van Wezel T; Cornelisse CJ
    BMC Cancer; 2008 Apr; 8():105. PubMed ID: 18416817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region.
    Chen T; Sahin A; Aldaz CM
    Cancer Res; 1996 Dec; 56(24):5605-9. PubMed ID: 8971163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
    Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
    Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
    Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemizygous deletions of chromosome band 16q24 in Wilms tumor: detection by fluorescence in situ hybridization.
    Shearer PD; Valentine MB; Grundy P; DeCou JM; Banavali SD; Komuro H; Green DM; Beckwith JB; Look AT
    Cancer Genet Cytogenet; 1999 Dec; 115(2):100-5. PubMed ID: 10598141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution integrated map encompassing the breast cancer loss of heterozygosity region on human chromosome 16q22.1.
    Frengen E; Rocca-Serra P; Shaposhnikov S; Taine L; Thorsen J; Bepoldin C; Krekling M; Lafon D; Aas KK; El Monéim AA; Johansen H; Longy M; Prydz H; Dorion-Bonnet F
    Genomics; 2000 Dec; 70(3):273-85. PubMed ID: 11161777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a high-resolution physical and transcription map of chromosome 16q24.3: a region of frequent loss of heterozygosity in sporadic breast cancer.
    Whitmore SA; Crawford J; Apostolou S; Eyre H; Baker E; Lower KM; Settasatian C; Goldup S; Seshadri R; Gibson RA; Mathew CG; Cleton-Jansen AM; Savoia A; Pronk JC; Auerbach AD; Doggett NA; Sutherland GR; Callen DF
    Genomics; 1998 May; 50(1):1-8. PubMed ID: 9628816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.
    Tsuda H; Callen DF; Fukutomi T; Nakamura Y; Hirohashi S
    Cancer Res; 1994 Jan; 54(2):513-7. PubMed ID: 8275489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LOH analyses of premalignant and malignant lesions of human breast: frequent LOH in 8p, 16q, and 17q in atypical ductal hyperplasia.
    Amari M; Suzuki A; Moriya T; Yoshinaga K; Amano G; Sasano H; Ohuchi N; Satomi S; Horii A
    Oncol Rep; 1999; 6(6):1277-80. PubMed ID: 10523696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of chromosome 16q loss differs between an atypical proliferative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast.
    Tsuda H; Takarabe T; Akashi-Tanaka S; Fukutomi T; Hirohashi S
    Mod Pathol; 2001 May; 14(5):382-8. PubMed ID: 11353046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer.
    Cleton-Jansen AM; Moerland EW; Kuipers-Dijkshoorn NJ; Callen DF; Sutherland GR; Hansen B; Devilee P; Cornelisse CJ
    Genes Chromosomes Cancer; 1994 Feb; 9(2):101-7. PubMed ID: 7513539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic significance of loss of heterozygosity in breast cancer].
    Iwase H; Iwata H; Toyama T; Hara Y; Omoto Y; Kobayashi S
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():426-30. PubMed ID: 9589047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.
    Grundy RG; Pritchard J; Scambler P; Cowell JK
    Br J Cancer; 1998 Nov; 78(9):1181-7. PubMed ID: 9820177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.